logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Ripple e SEC chegam em um acordo, encerrando o processo judicial
WEEX rouba a cena no BlockchainRIO 2025

Você também pode gostar

Compartilhar
copy

Ganhadores

Últimas notícias sobre cripto

23:53

Fed Futuras Reuniões Risco Vendo Incremento de Disputas Aumentando a Volatilidade do Mercado

23:51

Tom Lee: BTC e ETH Ratio Risk-Reward se tornando bastante atraente

23:49

O Coinbase agora está ao vivo com a negociação spot da Rayls (RLS)

17:51

Um determinado endereço de baleia depositou 10 milhões U em HyperLiquid, iniciando uma posição 20x ETH longa.

17:21

Coinbase to List Rayls (RLS)

Leia mais
Comunidade
icon
icon
icon
icon
icon
icon
icon
icon

Atendimento ao cliente@weikecs

Parcerias comerciais@weikecs

Quant trading e MM[email protected]

Serviços VIP[email protected]